Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide Infusion in Acute Brain Injury
NCT02058940Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2015
- Primary completion
- Aug 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in hyperglycemia, sponsored by University of North Carolina at Chapel Hill. Started Aug 2015; status: completed.
02
Drugs
exenatide
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT02058940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058940.